Palla Pharma Ltd Formerly known as Tpi Enterprises Ltd. Palla Pharma Limited, formerly TPI Enterprises Limited, is an Australia-based company, which is engaged in the manufacture and supply of alkaloids to international markets. The Company's segment is supplying narcotic raw materials (NRM), including morphine and thebaine to the active pharmaceutical ingredient sector. The Company uses its technology for solvent free extraction of alkaloids from opium poppies. It sources its raw materials from Australian poppy growers in Tasmania and Victoria. The Company assists customers with NRM conversions, such as methylation and oxidiation reactions. The Company sells and exports culinary poppy seed throughout Australia and around the world. The Company focuses on manufacture and supply of the products, including concentrate of poppy straw (oripavine), concentrate of poppy straw (thebaine), concentrate of poppy straw (morphine), concentrate of poppy straw (codeine), technical oripavine, technical codeine, noscapine and certified alkaloid impurities.

Sales Analysis. Palla Pharma Ltd reported sales of A$46.56 million (US$31.76 million) for the year ending December of 2018. This represents an increase of 109.1% versus 2017, when the company's sales were A$22.26 million. This was the third consecutive year of growth at Palla Pharma Ltd.